Drugs / DTaP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06184542 Comparator | Dec 2023 → Dec 2024 overdue | diphtheria, pertussis, tetanus | Institute of Medical Biology, Chinese Academy of Medical Sciences | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06184542 ↗ |
| Modality | Vaccine | “Diphtheria-Tetanus-acellular Pertussis Vaccine” NCT06184542 ↗ |
| Route | Intramuscular | “All toddlers will receive the injection in the deltoid muscle of the upper arm on Day 0.” NCT06184542 ↗ |